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ABSTRACT 
 
Endoplasmic reticulum (ER) dysfunction is important in the pathogenesis of many 
neurological diseases. In this review, we examine the evidence for ER 
dysfunction in a range of neurological conditions including cerebral ischaemia, 
sleep apnoea, Alzheimer’s disease, multiple sclerosis, amyotrophic lateral 
sclerosis, the prion diseases and Familial Encephalopathy with Neuroserpin 
Inclusion Bodies (FENIB).  Protein misfolding in the endoplasmic reticulum 
initiates a well-studied ‘Unfolded Protein Response’ in energy-starved neurones 
during stroke that is relevant to the toxicity of reperfusion.  The toxic peptide Aβ 
induces ‘ER stress’ in Alzheimer’s disease leading to activation of similar 
pathways, while the accumulation of polymeric neuroserpin in the neuronal ER 
triggers a poorly understood ‘ER overload response’.  In other neurological 
disorders such as Parkinson’s and Huntington’s diseases ER dysfunction is well 
recognised but the mechanisms for this are less clear.  By targeting components 
of these signalling responses, it may prove possible to ameliorate their toxic 
effects and treat a range of neurodegenerative conditions. 
 
Word count: 157 
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Introduction 
 
It can be argued that most neurodegenerative disorders arise from defective 
protein folding.  This is clearly true for those rare disorders caused by the 
misfolding of mutated neuronal proteins such as Huntington’s disease, but it is 
also the case for common disorders such as cerebral ischaemia where the lack 
of energy can impair normal protein folding 1 and sporadic Alzheimer’s disease 
where protein aggregation causes cellular stress 2-4.  Even some infectious 
neurodegenerative disorders such as the prionopathies arise from abnormal 
protein folding 5-9.  Consequently, the processes for disposing of misfolded 
proteins are the focus of much research.  Although the subcellular location of 
protein misfolding may differ between these disorders, it appears that the 
interdependence of protein folding throughout the cell results in ER dysfunction 
being the final common pathway for many, if not all, of these diseases (Table 1). 
 
ER Dysfunction 
The endoplasmic reticulum (ER) is required for folding of all secreted and 
membrane proteins and insults that impair its function induce a pathological state 
termed ‘ER stress’ 10.  This triggers an adaptive programme called the Unfolded 
Protein Response (UPR), which combines the early inhibition of protein synthesis 
with a later upregulation of genes that promote protein folding or disposal 10.  
Both the translational and transcriptional components of the UPR protect the 
neurone from becoming overwhelmed by misfolded ER proteins; however, when 
the insult is too great, apoptotic cell death frequently ensues.  While many cells 
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are relatively protected from accumulating misfolded protein through continued 
dilution of their ER by cell replication, this process is unavailable to post-mitotic 
neurones, which depend exclusively on the UPR.  Even glial cells, which can 
replicate, are susceptible to ER stress owing to their highly developed secretory 
pathway.   
 
It is important that the UPR be distinguished from the less well-understood ER 
Overload Response (EOR) 11.  The former is triggered by protein misfolding 
within the ER lumen, while the latter occurs when well-folded or misfolded 
proteins accumulate and distend the ER.  In this review, we will discuss the 
relevance of these forms of ER dysfunction to neurological disease, since a 
better understanding of each is likely to identify novel therapeutic strategies 
(Panel 1).  We will focus on ischaemic stroke, Alzheimer’s disease and 
Parkinson’s disease to discuss ER stress, while using Familial Encephalopathy 
with Neuroserpin Inclusion Bodies (FENIB) to illustrate ER overload, since these 
are the diseases for which the most evidence currently exists.  In addition, we will 
discuss the evidence for ER dysfunction in multiple sclerosis, amyotrophic lateral 
sclerosis and the prion disorders.  Some neurological disorders provoke ER 
stress signalling despite being caused by the accumulation of protein within the 
cytoplasm, for example Huntington’s disease 12.  Such disorders emphasise the 
interdependence of protein folding networks in the neurone and so shall be 
discussed as examples of disordered protein homeostasis or ‘proteostasis’. 
 
ER stress signalling 
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The signalling pathways triggered by ER stress comprise the UPR 10(Figure 1).  
Although it may seem tiresome to dwell on individual molecular components, this 
is unavoidable when studying a phenomenon as complex as ER stress.  Not 
least, because many of the measures commonly used to detect and quantify ER 
stress are themselves components of the UPR.  Some of these are activated 
transiently and so their absence cannot be used as evidence for a lack of ER 
stress 10, 13; conversely, certain components can be activated by stresses other 
than ER protein misfolding and so need to be interpreted with caution.  We shall 
therefore begin with a review of the major mediators of ER stress signalling with 
an emphasis on their role in neurones before moving on to considering specific 
examples of neuropathology mediated by ER dysfunction. 
 
• PERK 
Whenever misfolded protein accumulates in the ER lumen, new protein synthesis 
is rapidly inhibited 14.  This occurs because ER stress activates the PKR-like 
Endoplasmic Reticulum eIF2α Kinase (PERK), also know as Pancreatic eIF2α 
kinase (Pek) because of the tissue in which it was first discovered 14.  This kinase 
is ubiquitously expressed but is most important in highly secretory tissues such 
as the brain where it functions to match protein synthesis with the efficiency of 
protein folding in the ER 15.  When protein folding is progressing well PERK is 
inactive, but when misfolded ER proteins accumulate the kinase is activated and 
phosphorylates eukaryotic translation initiation factor 2α (eIF2α) (Figure 1) 16.  
This substrate is a subunit of the heterotrimeric GTP-binding complex eIF2 that 
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regulates the initiation of protein synthesis 14.  EIF2 recruits the methionyl-tRNA 
to the ribosome at the onset of protein translation, but when its eIF2α subunit is 
phosphorylated this activity is lost and translation ceases.  The load of proteins 
entering the ER is thus reduced following PERK activation preventing the 
accumulation of more misfolded proteins.   
 
• ATF4 
Despite the inhibition of protein translation that accompanies phosphorylation of 
eIF2α, a small subset of mRNAs is translated more efficiently under these 
conditions 17.  The best characterised of these is Activating Transcription Factor 4 
(ATF4), which triggers a transcriptional programme of stress-responsive genes 
17.  Other members of the eIF2α kinase family can inhibit translation and activate 
these genes; for example PKR responds to viral infection, HRI to iron deficiency 
and GCN2 to amino acid starvation 18.  This ability of eIF2α phosphorylation to 
mediate a response to multiple stresses led to this pathway being named the 
Integrated Stress Response 19.  Surprisingly, within the brain this can provoke 
specific behavioural responses.  A lack of essential dietary amino acids triggers 
the phosphorylation of eIF2α in the anterior piriform cortex by GCN2, which alters 
feeding behaviour in rodents 20, 21.  Thus, phosphorylation of eIF2α is not 
synonymous with ER stress and multiple lines of evidence should always be 
sought when attributing phosphorylation of eIF2α to ER dysfunction. 
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Phosphorylation of eIF2α is particularly important for the maintenance of axonal 
myelination in the human central nervous system (Table 1); indeed mutations 
that disrupt the regulation of eIF2α result in white matter hypomyelination 
disorders such as Childhood Ataxia with Central nervous system 
Hypomyelination (CACH syndrome) and Vanishing White Matter (VWM) 22.  This 
family of autosomal recessive conditions constitutes a spectrum of severity from 
congenital to adult-onset, involving the progressive loss of mental and motor 
function due to a loss of brain white matter.  In all cases, the causative mutations 
are found within subunits of eIF2B, a guanine nucleotide exchange factor (GEF) 
responsible for recharging the eIF2 complex with GTP 23, 24 (Figure 1).  These 
mutations interfere with the GEF activity of eIF2B and enhance the synthesis of 
ATF4.  This deregulates many target genes including components of a negative 
feedback system, including CHOP and GADD34, that normally recover protein 
translation following its initial inhibition by PERK 13, 25.   
 
• CHOP 
The transcription factor CHOP is induced by ATF4 and has widely been thought 
to be pro-apoptotic during ER stress, since Chop-/- animals are resistant to ER 
stress-induced cell death 13.  However, this is inconsistent with observations 
made in neurological diseases.  For example, CHOP expression is clearly anti-
apoptotic in mouse models of the X-linked disorder Pelizaeus-Merzbacher 
leukodystrophy caused by abnormalities of the proteolipid protein 1 (PLP1) gene 
26.  Indeed, identification of the target genes of CHOP failed to reveal a link with 
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apoptosis but instead identified genes that promote protein secretion 13.  This led 
us to suggest that in models of severe ER stress the promotion of protein 
secretion by CHOP might increase the intensity of stress and thus induce cell 
death 13.  By contrast, during conditions of milder ER stress, for example in 
Pelizaeus-Merzbacher leukodystrophy, it is likely that CHOP does not enhance 
ER stress sufficiently to trigger cell death 26.  These observations highlight the 
need to model not only the nature of the stress, but also its intensity and duration 
since differences in either can significantly affect the outcome and thus lead to 
beneficial or deleterious effects depending upon the context.  There may also be 
cell type specific consequences of expressing CHOP.  For example, while 
deletion of Chop worsens the central hypomyelination seen in Pelizaeus-
Merzbacher leukodystrophy 26, Chop-/- animals are protected against the 
peripheral hypomyelination caused by mutant myelin protein zero (P0) in mouse 
models of Charcot Marie Tooth type 1B 27. 
 
• GADD34 
A critical target gene of CHOP encodes Growth Arrest and DNA Damage-
inducible protein 34 (GADD34), which is a regulatory subunit of protein 
phosphatase 1 (PP1) 13.  This dephosphorylates eIF2α and thus brings about the 
recovery of protein translation after its initial inhibition.  It has been shown in mice 
that inactivation of the Gadd34 gene can protect animals from tissue damage 
during ER stress by reducing the accumulation of misfolded proteins 13.  
Subsequently, a small molecule called salubrinal was identified that increases 
 10 
the level of eIF2α phosphorylation and promotes survival of ER-stressed cells 28.  
It has been suggested that salubrinal may be an inhibitor of the eIF2α 
phosphatases 28, but direct evidence for this is lacking.  Recently, however, a 
selective inhibitor of GADD34, guanabenz, has been identified confirming the 
beneficial effects of GADD34 inhibition during ER stress at least in cultured cells 
29.  It is therefore likely that future therapies involving the inhibition of GADD34 
will be able to modulate ER stress.  
 
• ATF6 
In addition to the Integrated Stress Response genes regulated by PERK and 
ATF4, many additional genes are induced during the UPR by two further ER 
stress sensors, Inositol-Requiring Enzyme 1 (IRE1) and Activating Transcription 
Factor 6 (ATF6) 10 (Figure 1).  Like PERK, both are ER membrane proteins that 
are held inactive under normal conditions by the binding of the ER chaperone 
Binding Immunoglobulin Protein (BiP; also known as GRP78).  During stress, 
misfolded proteins sequester BiP, freeing ATF6 to traffic to the Golgi apparatus 
where it is cleaved to release a soluble transcription factor.  Of note, astrocytes 
express an ATF6-related protein called OASIS (Old Astrocyte Specifically 
Induced Substance) whose functions appear to overlap partially with those of 
ATF6 30.  This might enable astrocytes to respond to ER stress in a tissue-
specific manner.   
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While cleavage of ATF6 is strong evidence of ER stress, this is difficult to detect.  
Consequently, many studies fail to measure this arm of the UPR, but the use of 
sensitive reporters that measure the binding of ATF6 to specific DNA sequences 
can circumvent this problem in vitro 11. 
 
• IRE1 
The activation of IRE1 closely resembles that of PERK but, unlike PERK, IRE1 
triggers splicing of the mRNA encoding the transcription factor X-box Binding 
Protein 1 (XBP1) 31.  This induces a frame shift that generates the active form of 
this protein.  Like phosphorylation of eIF2α, the splicing of XBP1 mRNA is 
transient 13.  Following the alleviation of ER stress by the induction of UPR target 
genes, spliced XBP1 mRNA is rapidly lost from the cell to be replaced by the 
unspliced form 13.  In laboratory studies, supra-physiological levels of ER stress 
can cause complete splicing of XBP1 mRNA, but in vivo stresses are frequently 
subtler and so it is rare to observe complete splicing and careful quantification is 
therefore necessary 32. 
 
If proteins fail to fold in the ER, they are prevented from progressing along the 
secretory pathway and eventually are targeted for degradation 33.  This ‘ER-
associated protein degradation’ (or ERAD) returns terminally misfolded proteins 
to the cytosol where they are ubiquitinated by ER-associated ubiquitin ligases for 
degradation by the proteasome 34.  Many components of the ERAD machinery 
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are target genes of XBP1 and so the capacity for ERAD is increased by 
activation of IRE1 35.   
  
ER dysfunction in neurological disease  
Cerebral hypoxia 
In industrialized countries stroke is the third biggest killer and the leading cause 
of disability in adults. Acute ischaemia is the main cause of neuronal loss and, 
although its pathology is complex, appears to involve ER stress 1, 15, 36-38.  During 
cerebral ischaemia, neuronal depolarization due to energy depletion causes the 
uncontrolled release of glutamate.  The consequent activation of NMDA 
receptors on nearby neurones generates further glutamate release and causes 
an ischaemic depolarization wave to spread outward from the initial site of 
damage leading to widespread disturbance of calcium homeostasis 39.  
Unsurprisingly, many studies implicate ER calcium store release in the resulting 
excitotoxic death (reviewed in reference 39).   
 
The ER is the main site for calcium storage within the cell and so its chaperones 
have evolved to function efficiently in this high calcium environment; indeed 
many require high calcium to function 40.  Calcium is pumped into the ER by the 
sarcoendoplasmic reticular calcium-ATPase (SERCA) and released back into the 
cytosol by the inositol trisphosphate receptor (IP3R) in response to extracellular 
signals and by the ryanodine receptor during calcium-induced calcium release 39.  
Inhibition of the SERCA pump by thapsigargin induces apoptosis in many cell 
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types including neuroblastoma cells and is often used to induce ER stress in the 
experimental setting 41.  During cerebral ischaemia, energy depletion leads to 
failure of the SERCA pump and thus redistribution of ER calcium into the cytosol.  
This delivers a double blow with combined toxicity from uncontrolled cytosolic 
calcium and ER stress due to chaperone dysfunction (Figure 2) 39.  
 
The UPR is activated in many rodent models of cerebral ischaemia 1, 36.  In these 
models, protein synthesis is rapidly inhibited and accompanies the 
phosphorylation of eIF2α.  Although the inhibition of translation has been 
attributed to aggregation of components of the translation machinery 42, the 
primary mechanism appears to be through phosphorylation of eIF2α 43, which 
can remain phosphorylated for up to twelve hours following ischaemia 44.  PERK 
is the sole eIF2α kinase activated by cerebral ischaemia and predictably Perk-/- 
mice fail to show eIF2α phosphorylation following transient cerebral ischaemia 
and fail to reduce protein translation during the reperfusion period 15.  Even with 
the far milder recurrent cerebral hypoxia seen in obstructive sleep apnoea, 
activation of PERK has been described and has been suggested to play a role in 
the loss of upper airway motor neurones in this condition 45. 
 
IRE1 is also activated during cerebral ischaemia leading to the induction of UPR 
target genes 37, 38.  It appears to promote activation of pro-apoptotic caspase-12 
in cultured rodent cells and this has been detected in ischaemic rodent brains 46.  
However, caspase-12 is non-functional in the majority of humans, except those 
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from sub-Saharan Africa, owing to a common truncating mutation 47.  For this 
reason, it has been proposed that during ER stress in humans, caspase-4 might 
serve an analogous function to that of caspase-12 in rodents 48.   
 
Due to the problems of detection referred to earlier, the role of ATF6 during 
ischaemia is unclear.  ATF6 gene expression is elevated following transient 
middle cerebral artery occlusion in rats 36, but its activation has not been 
detected in rat brain following cardiac arrest and resuscitation 49.  OASIS is also 
upregulated and appears to play a neuroprotective role in response to kainate 
excitotoxicity 50.   
 
CHOP is induced following forebrain ischaemia in a variety of rodent models 
including bilateral common carotid 51, 52 or middle cerebral artery occlusion in 
mice 44 and global cerebral ischaemia in rats 53.  The location within the brain of 
CHOP induction appears to correlate well with subsequent cell death 53, 54 and 
deletion of the Chop gene protects mice during bilateral common carotid artery 
occlusion 52.  Similarly, depletion of CHOP using RNA interference partially 
prevents the death of astrocyte cultures stressed by oxygen-glucose depletion 55.  
As discussed, some of the toxicity attributable to CHOP reflects increased protein 
translation mediated by GADD34 13.  Indeed, GADD34 induction is well-
recognised to accompany cerebral ischaemia 56 being detected at the peri-infarct 
penumbra within two to twenty-four hours 57 and accounts for the transient nature 
of eIF2α phosphorylation during stroke 15.  Attenuation of translation protects the 
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cell from accumulating misfolded proteins, thus treatment with salubrinal (a drug 
that enhances eIF2α phosphorylation) reduces ER stress and promotes cellular 
survival in kainate-induced neurotoxicity 58.  Indeed, salubrinal has been shown 
to limit infarct size in a murine model of stroke 1. 
 
In addition to attenuating protein translation, the UPR leads to upregulation of ER 
molecular chaperones, the most abundant being BiP 10.  Following transient 
forebrain ischaemia, BiP expression in the hippocampus and cortex peaks 
between twelve to seventy-two hours after reperfusion 54, 59, but can remain 
elevated for up to two weeks 36.  This is protective, since suppression of BiP 
enhances apoptosis in hippocampal neurones exposed to excitotoxic and 
oxidative insults 60, while its overexpression in primary astrocyte cultures is 
protective against oxygen-glucose deprivation 61.  Indeed, higher levels of BiP 
induction correlate with neuronal protection 37, 62.   
 
Induction of the ER chaperone ORP150 (150-kDa oxygen-regulated protein) is 
also seen in ischaemic neurones, and over-expression of ORP150 protects mice 
from cerebral ischaemia 63.  ORP150 modulates the activity of BiP, which exists 
in either an ATP- or ADP-bound form, each with different substrate-binding 
affinity.  ORP150 functions as a nucleotide exchange factor for BiP to replace its 
bound ADP with ATP.  Interesting, another BiP nucleotide exchange factor, SIL1, 
is mutated in the Marinesco-Sjogren syndrome of cerebellar ataxia in which 
homozygous loss of SIL1 leads to ER stress and selective loss of cerebellar 
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Purkinje cells 64.  When ATP-BiP binds its substrate protein, a co-chaperone of 
the DnaJ family is required to stimulate BiP’s ATPase activity and so promote 
high affinity substrate binding.  The relative levels of ADP-BiP and ATP-BiP 
appear to be important for neuronal survival, since the toxicity of SIL1 loss can 
be ameliorated by the deletion of an ER luminal DnaJ co-chaperone called p58IPK 
65.  While loss of SIL1 would be predicted to reduce the level of ATP-BiP through 
impaired nucleotide exchange, loss of p58IPK is likely to restore balance by 
lessening BiP’s ATPase activity.  
 
When taken together, these observations suggest that ER stress is induced by 
cerebral ischaemia and that the UPR limits cerebral infarct size.  There is good 
evidence to suggest that manipulation of ER stress signalling by increasing 
phosphorylation of eIF2α may have important therapeutic effects as an acute 
intervention for cerebral ischaemia.  
  
Alzheimer’s disease 
Often presenting with failing memory, Alzheimer’s disease (AD) is a relentlessly 
progressive neurodegenerative disorder and the most common cause of 
dementia in adults.  The classic histopathological features consist of extracellular 
plaques of the β-amyloid (Aβ) peptide and intracellular neurofibrillary tangles of 
hyperphosphorylated aggregates of the microtubule-associated protein tau.  
Studies of familial AD demonstrate that the disorder is caused by overproduction 
of the more aggregation-prone Aβ1-42 peptide 66 (Figure 3).  Despite decades of 
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study, the molecular pathology of this disease remains unclear.  However, 
increasing evidence suggests that ER stress may represent a new paradigm for 
understanding this condition. 
 
Studies using post-mortem tissue from the brains of individuals with AD have 
provided evidence for ER dysfunction in this disease.  But when looking at a 
single marker of ER stress, such studies can generate confusing results.  For 
example, when BiP is examined in isolation it can show no change 3, a decrease 
67 or even an increase 2, 68, although BiP expression does seem to be higher in 
brains with histologically more advanced disease 68, 69.  However, whilst often a 
useful indicator, the level of BiP expression is inadequate alone to assess the 
activation of UPR signalling, especially in a chronic disorder in which histological 
features evolve over time.  It has therefore proved more useful to include 
additional markers of the UPR in such studies.  For example, protein disulphide 
isomerase, another target of the UPR, is elevated in the temporal lobes of the 
brains of individuals with AD 3, associated with neurofibrillary tangles in the 
hippocampus and frontal lobes and in dystrophic neurites of senile plaques 4.  
When one looks for more proximal markers of UPR signalling, there is activation 
of PERK in the hippocampus of AD brains, which appears to co-localise with 
staining for phosphorylated tau and correlates with histological staging 70, 71. Yet 
phosphorylated PERK is barely detectable in tangle-bearing neurones 
themselves, suggesting that PERK is activated at the pre-tangle stage in 
neurones of the hippocampus 71.  In addition, there are elevated levels of spliced 
 18 
XBP1 mRNA in the temporal cortex of AD patients when compared to age-
matched controls 3.  Congruently, a marked increase in the number of neurones 
immunoreactive for phosphorylated (active) IRE1α has been detected in the 
hippocampus of individuals with AD 71. 
 
There is good evidence for activation of PERK in laboratory models of AD.  
Increased BiP expression observed upon application of exogenous Aβ to primary 
cortical neurones suggests that accumulation of the peptide may directly activate 
ER stress signalling 72, 73.  Moreover, exogenous Aβ has been found to increase 
the phosphorylation of PERK and eIF2α in cultured neuronal cells 73, 74, while 
silencing of PERK by siRNA in Aβ42-treated cells limits eIF2α phosphorylation 
and enhances cell death 73.  In addition, Aβ42 treatment induces CHOP 
expression both in cultured cells and in rabbit hippocampus 75, 76, while prior 
treatment of cells with CHOP anti-sense RNA improves survival following 
exposure to the Aβ peptide, suggesting a role for CHOP in Aβ-mediated death 77.  
In Drosophila neurones or mammalian PC-12 cells, exposure to Aβ induces 
XBP1 mRNA splicing and in both models overexpression of spliced XBP1 is 
protective, while knockdown of XBP1 exacerbates Aβ toxicity 78.  
 
PC-12 cells overexpressing mutant forms of presenilin 1 (PS1), a component of 
the γ-secretase, that has been linked to familial AD, show increased levels of 
phosphorylated eIF2α, as do hippocampal homogenates from PS1 mutant 
knock-in mice 79.  PC-12 cells expressing mutant PS1 have elevated levels of 
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CHOP, as do knock-in mice expressing mutant PS1 79.  The nature of the 
interaction between PS1 and ER stress has yet to be fully elucidated, although it 
is known that PS1 and the SERCA calcium pump physically interact with one 
another 80.  As discussed, disordered calcium homeostasis is a potent cause of 
ER stress and much evidence suggests that calcium signalling is perturbed in 
Alzheimer’s disease 81 (reviewed in reference 82).  Interestingly, ER stress 
induced by tunicamycin, a glycosylation inhibitor frequently used to induce ER 
stress in vitro, increases PS1 expression in multiple cell lines including 
neuroblastoma 80.  Recent evidence suggests that phosphorylation of eIF2α by 
PERK during ER stress can increase the level of β-site APP cleaving enzyme-1 
(BACE) and thereby promoting amyloid formation 83.  This suggests that the 
interaction between AD and ER stress may prove to be bi-directional.   
 
ER stress has been shown to alter APP localization, processing and degradation 
by the ERAD machinery 84 (Figure 4).  During ER stress, immature forms of APP 
bind to BiP and when BiP is overexpressed Aβ generation is reduced as APP is 
retained in earlier compartments of the secretory pathway 84.  The ERAD 
ubiquitin ligase HRD1 promotes APP ubiquitination and degradation in HEK293 
cells reducing the generation of both Aβ40 and Aβ42 2.  In addition, an intronic 
polymorphism (IVS3-88A>G) of SEL1L, another component of the ERAD system, 
has been associated with AD in an Italian population 85.  These hints that ERAD 
is important in the pathogenesis of AD still require further validation.  But there is 
accumulating evidence for elevated UPR signalling in AD and, combined with the 
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support from model systems, provides a potential mechanism by which the Aβ 
peptide and mutants of PS1 might induce ER stress. This offers the potential to 
identify new therapeutic targets in an otherwise incurable disease.   
 
Parkinson’s disease 
With age, 2% of the population suffer the loss of dopaminergic neurones in their 
nigrostriatal pathway and so develop Parkinson’s disease (PD) characterised by 
hypokinesia, rigidity and tremor.  Post-mortem studies identify characteristic 
Lewy body inclusions in many affected brains, suggesting aberrant protein 
disposal as a possible cause, while toxins that cause Parkinsonism, such as 
MPTP, rotenone and 6OHDA, impair mitochondrial function and promote ER 
stress 86-90.   
 
Multiple lines of evidence point towards a role for ER stress in the pathogenesis 
of PD.  For example, excess levels of dopamine are toxic to PC-12 cells, which 
correlates with their induction of ER chaperones 91.  The brains of patients 
suffering from sporadic PD, but not controls, have elevated levels of 
phosphorylated PERK and eIF2α 92.  Perk-/- sympathetic neurones are 
hypersensitive to 6OHDA 92, while overexpression of spliced XBP1 is protective 
both in cultured cells and animals treated with MMP+/MPTP 87.  CHOP 
expression is increased both by 6OHDA and MPTP, and knockout of the Chop 
gene is protective in mice treated with 6OHDA 93.  
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In Japanese and European families with the juvenile onset autosomal recessive 
variant of PD (ARPD), classical genetic mapping identified the disease-
associated gene PARK2 94.  This encodes an ubiquitin ligase Parkin, whose 
activity is lost with disease-associated mutations 95.  Parkin was suggested to 
localize to the ER and to be upregulated during the UPR 96.  A major function of 
Parkin appears to involve targeting defective mitochondria for destruction by 
autophagy 97.  It is possible that impaired mitochondrial function in patients with 
PARK2 mutations manifests as ER stress owing to defects in energy supply 
during ER protein folding.  However, another component of Lewy bodies, α-
synuclein, can be found throughout the cell including the ER lumen and may also 
be a target of Parkin 98.  Mutations of α-synuclein cause an autosomal dominant 
form of PD 99, while the glycosylated ER-form of α-synuclein has been shown to 
be ubiquitinated by Parkin and to accumulate in a non-ubiquitinated form in the 
brains of individuals with Parkin deficiency 98. Overexpression of α-synuclein 
induces ER stress 100, perhaps through binding to BiP 101, while PDI appears to 
impair α-synuclein fibril formation 100.  Recently, oligomers of mutant α-synuclein 
were shown to accumulate within the ER in an animal model and to trigger the 
UPR, albeit with relatively little PERK activation 102.  When eIF2α phosphorylation 
was augmented with salubrinal, the accumulation of α-synuclein oligomers was 
ameliorated and disease onset was delayed.  There is further evidence that 
modulating the levels of ER stress may be beneficial in PD, since 4-PBA, which 
has been shown to possess ‘chemical chaperone activity’ that can protect cells 
from ER stress, rescues cells from the neurotoxicity of rotenone 103 and ‘pre-
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conditioning’ neuroblastoma cells with ER stress to up-regulate chaperone levels 
can protect the cells from subsequent challenge with 6OHDA 104.   
 
Huntington disease 
Huntington disease (HD) is an inherited autosomal dominant disorder 
characterised by motor dysfunction, psychiatric disturbances and intellectual 
decline.  It is caused by expansions of CAG repeats within the HTT gene 
encoding huntingtin and so represents an archetypal poly-Q disease.  In health, 
the normal HTT gene contains 6 to 35 repeats, while in patients affected by HD 
there may be more than 40, which generates a protein prone to aggregation.  
Although this aggregation takes place in the cytosol this has been shown to 
provoke ER stress 105.   
 
It is now appreciated that perturbations of protein folding within one organelle can 
be propagated to another.  This concept of cell-wide protein homeostasis, or 
‘proteostasis’, may be especially relevant to HD and other poly-Q disorders 
wherein cytoplasmic aggregates trigger the UPR 106.  The precise mechanism 
linking aggregation in the cytosol with malfunction of the ER is poorly understood; 
however, expression of poly-Q proteins and mutant huntingtin in cells has been 
shown to bind components of the ERAD machinery and impair their function 12, 
107.  It is possible that huntingtin is a target of the ERAD ubiquitin ligase HRD1, 
since HRD1 can ameliorate the toxicity of the poly-Q protein 107.  By sequestering 
HRD1 and other components, huntingtin might reduce the capacity of a neurone 
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to cope with misfolded proteins by ERAD, thereby rendering them more 
vulnerable to ER stress 12.   In addition, while chronic ER stress is known to 
induce cell death in some circumstances, it might also impair intracellular 
signalling in viable cells.  Recent data suggest that ER calcium release via the 
IP3R1 channel is impaired by ER stress in HD owing to the loss of a stimulatory 
interaction between BiP and this channel 108.  
 
Amyotrophic lateral sclerosis  
Amyotrophic lateral sclerosis (ALS) involves the progressive loss of motor 
neurones causing an irreversible decline of muscle power and death usually 
within five years.  The aetiology remains largely unknown, although 5-10% of 
cases display a dominant pattern of inheritance suggestive of a toxic-gain-of-
function, so-called Familial ALS (FALS).  Of these, a fifth are caused by 
mutations in the copper-zinc superoxide dismutase 1 (SOD1) that accumulates 
as fibrils in Lewy Body-like hyaline inclusions, the histological hallmark of FALS. 
 
Post-mortem brains from ALS patients show elevated levels of markers of ER 
stress 109.  Furthermore, disease models of FALS implicate ER stress in its 
pathogenesis.  Although SOD1 was thought to be an abundant cytosolic protein, 
it is also secreted by multiple cell types and co-localises with ER markers 110.  
When expressed in cultured cells or in animal neuronal tissue, mutant SOD1 
accumulates within the ER and upregulates targets of the UPR 111-113.   
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Activation of PERK can be detected in animals prior to the development of overt 
disease 114 and it has been shown in three models of FALS that a subset of 
motor neurones are more sensitive to the toxic effects of mutant SOD1 and show 
evidence of ER stress at a younger age 115.  When one allele of Perk is deleted in 
mice expressing a mutant form of SOD1, onset of disease is accelerated, 
suggesting that phosphorylation of eIF2α is protective in this disorder 116.  This is 
supported by the protection of vulnerable neurones in animals treated with 
salubrinal 115.   
 
Surprisingly, deletion of neuronal XBP1 has been shown to delay the onset of 
disease extending the lives of FALS mice 117.  In cultured neurones depletion of 
XBP1 reduces SOD1 aggregates and toxicity through enhanced autophagy, 
which might plausibly explain this apparent neuroprotection through increased 
clearance of aggregated protein.  Similarly, enhanced degradation of SOD1 by 
overexpression of ERAD protein derlin1 ameliorates SOD1-induced cell death 
118.  Though mutant SOD1 has been shown to interact with derlin1 and so impair 
ERAD to promote ER stress 119.  
 
Multiple sclerosis 
Regulated phosphorylation of eIF2α is important for the health of myelinated 
neurones within the central nervous system as illustrated by the CACH/VWD 
syndrome and Pelizaeus-Merzbacher leukodystrophy as mentioned previously.  
This holds true in multiple sclerosis (MS), although the timing of eIF2α 
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phosphorylation relative to the onset of disease determines its consequences.  In 
the experimental autoimmune encephalitis (EAE) model of MS, ER stress can 
hasten or delay disease progression if induced after of before disease onset 
respectively 120, 121; a phenomenon previously seen with interferon treatment.  
Indeed, both EAE and interferon cause phosphorylation of eIF2α by PERK.  Only 
when animals are exposed to interferon prior to EAE is a protective ‘pre-
conditioning’ seen and, importantly, the protection is lost if one allele of Perk is 
deleted 120.  In contrast, interferon treatment of animals with established EAE 
exacerbates their ER stress and worsens demyelination through impaired 
oligodendrocyte survival. 
 
FENIB 
Ten years ago, the first cases of a new familial encephalopathy with inclusion 
bodies (FENIB) were described in two families living in the USA 122.  The primary 
symptom of this autosomal dominant neurodegenerative disease was pre-senile 
dementia.  In each family, eosinophilic neuronal inclusions were observed in the 
deeper layers of the cerebral cortex and in the substantia nigra (Figure 5).  After 
isolation and sequencing of these inclusions, it was demonstrated that they were 
composed of a single protein, neuroserpin.  When expressed in neurones, the 
mutants of neuroserpin accumulate to form acid-Schiff-positive diastase-resistant 
inclusions in the ER, also called Collins’ bodies 122. 
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Neuroserpin is a member of the serine protease inhibitor (serpin) superfamily.  
Serpins are capable of polymerisation under certain circumstances and many 
examples of naturally occurring mutations exist that promote polymerisation 
leading to disease 123, 124.  The retention of polymerised neuroserpin within the 
ER causes neurotoxicity through a toxic gain-of-function, while the lack of 
secretion causes the activation of proteolysis and hence disease through a loss-
of-function 123.  
 
Despite being retained in the ER, the polymerised mutants of neuroserpin fail to 
activate the UPR 11.  Instead, these polymers induce NFκB signalling in a 
calcium-dependent manner 11.  This is reminiscent of the ER overload response 
(EOR), which is activated by the accumulation of well-folded protein as happens, 
for example, in some viral infections 125.  The degradation of mutant neuroserpin 
involves the co-ordinated activity of both the ERAD and autophagic pathways 124.  
Since these pathways have successfully been targeted in preclinical studies of a 
related serpinopathy using the drug carbamazepine 126, there is hope for 
pharmacological treatment of this and other ER overload disorders.  Indeed, it is 
likely that similar strategies will prove beneficial in other diseases of protein 
accumulation, such as those described in the sections concerning ER stress.   
 
Prion diseases 
The nature of the ER dysfunction observed in prion diseases remains less clear.  
While ER stress pathways were activated in a cell model of Creutzfeldt-Jakob 
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disease (CJD), UPR signalling was not detected in a transgenic mouse model for 
prion disease 5.  Nevertheless, both primary neuronal cultures and PC-12 cells 
expressing PrP mutants develop dramatic ER swelling suggesting that ER 
homeostasis is perturbed 6. The failure to detect splicing of XBP1 mRNA or 
differences in BiP levels in prion disease models suggests that prion proteins 
might not elicit classical ER stress 5.  However, pharmacological induction of ER 
stress in neuronal cell lines expressing mutant PrP can decrease PrP levels 7.  
Recently it was shown that prion replication causes prolonged repression of 
protein translation leading to synaptic failure of neuronal loss 9.  In contrast to 
many ER stress-related disorders in which enhanced phosphorylation of eIF2α is 
protective, prion-induced neurodegeneration is enhanced by salubrinal while 
overexpression of GADD34 is protective.  The relationship between the 
prionopathies and ER dysfunction therefore requires further examination. 
 
Concluding remarks and therapeutic potential 
The evidence for activation of ER stress responsive pathways in a range of 
neurological conditions is strong.  What remains to be determined is how 
successful strategies that target these responses will be in treating these 
diseases.  The UPR signalling field has matured to a point at which small 
molecular inhibitors of its components are now being developed.  
 
The muscle relaxant dantrolene targets IP3R channels of the ER to prevent the 
release of calcium.  This provides neuroprotection in models of HD 127 and of 
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cerebral hypoxia-reperfusion injury, where its action is associated with reduced 
levels of ER stress 128.  Prolonging the phosphorylation of eIF2α and thus 
delaying the recovery of protein translation with agents such as salubrinal or 
guanabenz is another promising approach 28, 29.  Salubrinal has already been 
shown to reduce the accumulation of α-synuclein in models of ALS 102, 129, reduce 
the toxicity of Aβ to primary neurones 73, and lessen the ER stress associated 
with cerebral ischemia/reperfusion and models of HD 1, 130.  More recently, 
agents have been developed that inhibit IRE1, including quinotrierixin 131 and 
4µ8C 132.  Both selectively inhibit the splicing of XBP1 mRNA and the latter 
prevents expansion of the ER without obvious toxicity, which might have 
therapeutic utility to impede the formation of protein inclusions in neurones. 
 
The list of neurological disorders with impaired ER protein folding is already long 
and appears set to grow further for some time to come (Table 1).  It will therefore 
aid the neurologist and neuroscientist alike to appreciate the signalling pathways 
that communicate this failure of ER function to the rest of the cell, since it is likely 
these insights will inform research, diagnosis and ultimately therapy. 
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Panel 1 
Search Strategy 
We set out by searching the PubMed database with the terms “(endoplasmic 
reticulum) AND (brain OR neurological) AND disease” including only articles in 
English.  These titles and abstracts were screened and relevant papers were 
obtained for detailed assessment.  Their bibliographies were also screened for 
additional sources.  Papers published prior to September 2012 are included.  
Where possible, emphasis is given to articles published within the last 5 years. 
 
 
Figure legends 
 
Figure 1.  Endoplasmic reticulum stress signalling 
In health, newly synthesised secretory proteins are translocated into the ER 
lumen co-translationally.  They fold with the aid of chaperones, for example BiP. 
When recognised as correctly folded they exit the ER in COPII-coated vesicles 
and traffic along the secretory pathway.  During ER stress, misfolded proteins 
accumulate in the ER lumen and sequester BiP from the sensor molecules 
PERK, IRE1 and ATF6. PERK phosphorylates eIF2α, which binds and inhibits its 
guanine nucleotide exchange factor eIF2B.  This blocks new secretory protein 
synthesis and triggers the integrated stress response (ISR) through increased 
levels of ATF4.  Activation of IRE1 leads to generation of active XBP1, while 
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cleavage of ATF6 generates ATF6c.  These transcription factors co-operate to 
induce target genes of the unfolded protein response (UPR). 
 
Figure 2. ER stress during cerebral ischaemia 
During an ischaemic stroke, the lack of glucose and oxygen supply in neurones 
induces a dramatic fall in ATP production.  Without energy, BiP binds to unfolded 
proteins less efficiently resulting in the accumulation of misfolded ER client 
proteins and subsequent activation of the UPR.  In parallel, failure of the SERCA 
pump depletes ER calcium and worsens chaperone function still further. 
Extracellular tPA (tissue-type plasminogen activator) cleaves the NMDA receptor 
allowing calcium influx into the cytosol.  The resultant elevation of cytosolic 
calcium triggers calcium-induced calcium release via ryanodine receptors located 
in the ER membrane leading to calcium depletion from the ER.  In severely 
affected neurones, elevated cytosolic calcium ultimately induces cell death. In 
surviving neurones, induction of the eIF2α phosphatase GADD34 by ATF4 in a 
CHOP-dependent manner enables the eventual recovery of protein translation. 
This can contribute to reperfusion injury through increasing the level of ER 
protein load.  
 
 
Figure 3.  Alzheimer’s disease and ER stress 
(A) In health, amyloid precursor protein (APP) is cleaved sequentially by β-
secretase followed by γ-secretase in the TGN and early endosomes mainly 
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generating non-toxic Aβ40.  APP is recycled via the endosomal pathway.  (B) In 
Alzheimer’s disease, toxic Aβ42 is generated and secreted. Exogenous Aβ42 
causes ER stress via a poorly understood mechanism.  In some cases of familial 
Alzheimer’s disease, mutations in PS1 impair trafficking of APP, thereby 
enhancing Aβ42 secretion.  Mutated PS1 may also lead to APP processing within 
the ER.  
 
 
Figure 4: ERAD of amyloid precursor protein 
Newly synthesised proteins, for example amyloid precursor protein (APP), 
interact with ER chaperones during multiple folding cycles until they reach their 
native folded state.  Overexpression of BiP can increase retention of APP in the 
ER. If protein folding fails, the terminally misfolded client is targeted for 
degradation via ERAD.  The interaction of glycoprotein substrates with both the 
folding machinery and the ERAD machinery is governed by cycles of de-
mannosylation and re-mannosylation.  Eventually, low mannose species can 
interact with EDEM and be targeted for dislocation from the ER lumen into the 
cytosol.  This process is incompletely understood and displays substrate specific 
differences, but for APP involves a complex containing Hrd1 and Sel1L.  Once in 
the cytosol, the ERAD substrate is ubiquitinated and eventually degraded by the 
proteasome. 
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Figure 5: FENIB and the ER overload response 
(A) Eosin staining of cerebral cortex from individuals with wild-type neuroserpin 
(WT) and the S52R or G392E mutations.  Mutant protein is retained as polymers 
within the ER to form Collins bodies (red).  The rate of polymer formation 
correlates with the age at which symptoms develop and the amount of Collins’ 
bodies that can be detected.  (B) Monomeric serpins, for example neuroserpin, 
present a reactive centre loop (red) that functions as a pseudosubstrate for their 
target protease.  However, point mutations in the shutter domain (purple circle) 
open β-sheet A (green) to allow the insertion of the reactive centre loop 
belonging to a second serpin molecule.  If allowed to propagate, this loop-sheet 
linkage generates large stable pathological polymers that are retained in the ER 
to form Collins’ bodies.  (C) These polymers are formed of folded neuroserpin 
and therefore fail to activate the UPR.  Instead they cause the release of ER 
calcium into the cytosol, which causes NFκB activation and target gene 
induction. 
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